[Lyme borreliosis--the most frequent vector-borne infection in Denmark].
Lebech
Anne-Mette K
AM
H:S Rigshospitalet, Epidemiklinikken og Neurologisk Afdeling. Lebech@dadlnet.dk
Hansen
Klaus
K
D000818:Animals; D000900:Anti-Bacterial Agents / Q000008:administration & dosage; D000907:Antibodies, Bacterial / Q000032:analysis; D000954:Antigens, Surface / Q000008:administration & dosage; D001425:Bacterial Outer Membrane Proteins / Q000008:administration & dosage; D001428:Bacterial Vaccines; D025065:Borrelia burgdorferi / Q000276:immunology; D002443:Ceftriaxone / Q000008:administration & dosage; D003718:Denmark / Q000453:epidemiology; D004199:Disease Vectors; D004318:Doxycycline / Q000008:administration & dosage; D006801:Humans; D008074:Lipoproteins; D008193:Lyme Disease / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology* / Q000276:immunology; D022123:Lyme Disease Vaccines / Q000008:administration & dosage; D020852:Lyme Neuroborreliosis / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology* / Q000276:immunology; D010406:Penicillins / Q000008:administration & dosage
D000900:Anti-Bacterial Agents; D000907:Antibodies, Bacterial; D000954:Antigens, Surface; D001425:Bacterial Outer Membrane Proteins; D001428:Bacterial Vaccines; D008074:Lipoproteins; D022123:Lyme Disease Vaccines; C072045:OspA protein; D010406:Penicillins; D002443:Ceftriaxone; D004318:Doxycycline